Chinese manufacturers of oseltamivir generics?

Below is a brief overview of some of the most active Chinese companies that manufacture generic oseltamivir (commonly sold as Tamiflu® in many markets). The list is not exhaustive but highlights firms that have repeatedly submitted product dossiers to China’s National Medical Products Administration (NMPA) and have received approvals for marketing or export.

How the Process Works in China

1. GMP Certification – The manufacturer must have a GMP‑certified facility that meets NMPA standards (often also ISO 9001/13485).
2. Batch Testing – Each production batch undergoes rigorous in‑house and third‑party testing for potency, purity, dissolution, and stability.
3. NMPA Dossier Submission – The company submits a “generic drug application” (GDA) that includes chemistry, manufacturing, and control (CMC) data, pharmacokinetic equivalence studies, and safety data.
4. Review & Approval – The NMPA reviews the dossier, may request additional data, and, upon satisfaction, grants a “Drug Registration Certificate” (DRC) and a “Drug Production License” (DPL).
5. Export Licenses – For overseas markets, the company must obtain an export permit and, depending on the target country, meet the importing country’s regulatory requirements (e.g., FDA’s “GMP‑compliant generic” designation for the U.S.).

Where to Find More Detailed Information

• NMPA’s Official Database – Search by the drug name (oseltamivir) or the company name for registration certificates and approval dates.
• Company Annual Reports – Many listed companies (e.g., Hualan, Hengrui) publish drug‑specific manufacturing details in their 10‑K or annual reports.
• WHO Pre‑qualification List – Some Chinese manufacturers have WHO pre‑qualified APIs, which can be cross‑checked on the WHO’s website.
• Clinical & Regulatory Journals – Papers on the pharmacokinetic comparability of Chinese oseltamivir generics are often published in journals such as Drug Metabolism and Disposition or Journal of Pharmaceutical Sciences.

Quick Takeaway

If you’re looking to source oseltamivir from China—whether for research, clinical trials, or commercial distribution—you’ll typically find a few well‑established GMP‑certified firms that have already navigated the regulatory maze. For most generic applications, Hualan and Jiangsu Hengrui are the two most frequently cited names, with Shenzhen New Hope and Anhui Pharm also appearing regularly in international supply chains.

Feel free to let me know if you’d like more specific details about a particular manufacturer’s API quality, licensing status in a particular country, or guidance on how to initiate a regulatory submission for a generic oseltamivir product.